IHI - iShares U.S. Medical Devices ETF
| Previous Close | 190.40 |
| Open | 190.53 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 185.91 - 190.67 |
| 52 Week Range | 155.25 - 194.27 |
| Volume | 215,915 |
| Avg. Volume | 98,887 |
| Net Assets | 1.71B |
| NAV | 184.88 |
| PE Ratio (TTM) | N/A |
| Yield | 0.29% |
| YTD Return | 6.64% |
| Beta (3y) | 0.94 |
| Expense Ratio (net) | 0.44% |
| Inception Date | 2006-05-01 |
- Market Realist•15 days ago
Abbott’s Stock Price Momentum Continues: What’s Ahead?
On April 5, 2018, Abbott Laboratories (ABT) ended the trading day at $59.86 per share. The stock registered a rise of ~0.67% in its stock price compared to its previous day’s close. For more details, read Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results.
- Market Realist•20 days ago
What’s Driving Boston Scientific Stock Upward
Boston Scientific Acquires Securus Medical
- Motley Fool•last month
How to Invest in Healthcare Stocks the Easy Way
Here are several smart ways to invest in the companies that keep people healthy.
- Market Realist•last month
How TMO Stock Has Performed Recently
What Analysts Recommend for Thermo Fisher Scientific
- Market Realist•last month
Reading Dentsply Sirona’s Recent Stock Performance
Inside Dentsply Sirona’s New Turnaround Plan
- Market Realist•2 months ago
BSX Stock Rises More Than 2% Following EMcision Acquisition
Boston Scientific Stock Rises with Endoscopy Acquisition
Market Realist•2 months agoWhere Is SYK Stock Headed after Its Recent All-Time Highs?
On February 26, 2018, Stryker (SYK) closed trading at $165.77. According to Stryker, it has delivered sales growth consistently higher than that of the average performance of the medical technology industry over the past several years. The stock is currently trading above its 200-day moving average of $160.03 and its 50-day moving average of $160.03.
- Market Realist•2 months ago
Abbott Laboratories’ Stock Performance after a Recent Bull Run
Abbott Laboratories Updates: Dividend, Ratings, and More
Market Realist•2 months agoBSX Stock Regains Momentum after Its Recent Bearish Trend
BSX Stock Recovers after a Robust 4Q17: What's to Come?Boston Scientific’s recent stock performance
Market Realist•2 months agoWhat Analysts Recommend for Medtronic ahead of 3Q18 Earnings
What Investors Can Expect from Medtronic's 3Q18 Results
- Market Realist•2 months ago
BD Medical Segment Posted Strong Fiscal 1Q18 Performance
Becton Dickinson's Fiscal 1Q18 Results Beat Analyst Estimates
Market Realist•3 months agoAbbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results
What's Next for Abbott Laboratories after a Stellar 2017?The impact of 4Q17 earnings release on ABT’s stock price performance
Market Realist•3 months agoRationale behind Varian Medical’s Acquisition of Sirtex Medical
Varian Medical Systems Acquires Sirtex for $1.3 Billion
Market Realist•3 months agoZBH Stock Price Momentum Likely to Trend Upward
What to Expect from ZBH's 4Q17 Earnings Results
- Market Realist•3 months ago
ABT Stock Trading Near Its All-Time High: What’s Driving Growth?
What to Expect from Abbott Laboratories' 4Q17 Results
- Market Realist•3 months ago
Stryker’s Latest Valuation Metrics
Stryker's 52-Week High: Should You Expect Further Upside?
Market Realist•3 months agoStryker’s Stock Rally Continues with 52-Week High Yesterday
Stryker's 52-Week High: Should You Expect Further Upside?SYK stock at 52-week high On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4. As of January 9, 2018, SYK stock is trading higher than its 50-day moving average of $155 as well as the 200-day moving average of $148.1. Stryker traded at a 52-week low of $117.6 on January 9, 2017. The company’s one-year stock return is ~35% as of January 9, 2018.
Market Realist•3 months agoDiscussing Baxter International’s Recent Stock Price Highs
Baxter Reaches 52-Week High: What's behind the Stock Rally?Baxter International’s recent trading activity
- Market Realist•4 months ago
BD’s Stock Price Performance after Recent 52-Week High
On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock's 50-day moving average stands at $221.22.
- Market Realist•4 months ago
How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry
The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.
- Zacks•4 months ago
3 ETF Areas May Come Under Pressure on Tax Reform
These ETF areas may not profit out of Trump's tax reform.
- Zacks•5 months ago
ETF Strategies Based on Billionaires' Choices
How to profit from billionaires' investment decisions through ETFs.
- InvestorPlace•5 months ago
Mixed Prognosis for Healthcare Stocks
If someone had told you at the beginning of the year that the Republican-controlled Congress was going to try and fail to repeal and replace the Affordable Care Act (ACA) multiple times during 2017, you probably wouldn’t have believed them. You might think that this uncertainty would have taken a bearish toll on healthcare stocks, but you’d be wrong in most cases. Many healthcare stocks are keeping pace with, or outperforming, the S&P 500.
- Market Realist•7 months ago
Understanding BD’s Recent Stock Performance
BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.
